Asia-Pacific Biosurgery Market, By Product (Bone-Graft Substitutes, Soft-Tissue Attachments, Haemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers and Staple-Line Reinforcement Agents), Application (General Surgery, Cardiovascular Surgery, Orthopaedic Surgery, Neurological Surgery, Reconstructive Surgery, Gynaecological Surgery, Thoracic Surgery and Urological Surgery), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2028.
Market Analysis and Insights of Asia-Pacific Biosurgery Market
Data Bridge Market Research analyses that the Asia-Pacific biosurgery market will exhibit a CAGR of around 8.23% for the forecast period of 2021-2028. Rising geriatric population, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies and rising expenditure on the healthcare infrastructure development especially in the developing economies are the major factors attributable to the growth of biosurgery market.
Biosurgery is a surgical procedure that involves the use of livings organisms such as larvae or maggots. This ancient medical treatment has been prevalent even today owing to the benefits arrived out of it. The organisms eat of the infected area and unhealthy bodily growing.
Upsurge in the awareness about the benefits of biosurgery over traditional surgical methods are the major factors fostering the growth of the market. Rising focus on the healthcare technological advancements for the development of new and advanced products coupled with rising demand of minimally prominent surgery is another market growth determinant. Rising research and development proficiencies, ever-rising geriatric population and rising incidences of joint reconstruction and spinal fusion will further generate lucrative market growth opportunities.
However, stringent regulations on product approvals will further derail the market growth rate. Unfavourable reimbursement scenario in the developing and underdeveloped economies will further pose challenges for the market. Complications associated with the surgeries will also hamper the market growth rate.
This Asia-Pacific biosurgery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Asia-Pacific biosurgery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Asia-Pacific Biosurgery Market Scope and Market Size
The Asia-Pacific biosurgery market is segmented on the basis of product and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the Asia-Pacific biosurgery market is segmented into bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants and adhesives, adhesion barriers and staple-line reinforcement agents. The bone-graft substitutes are further sub-segmented into demineralized, bone matrix, synthetic bone grafts, bone morphogenetic proteins and others. The soft-tissue attachments segment can also be bifurcated into synthetic meshes and biological meshes. Hemostatic agents are further bifurcated into thrombin-based hemostatic agents, oxidized regenerated cellulose-based hemostatic agents, combination hemostatic and agents. Surgical sealants and adhesives can be also further sub-segmented into natural/biological sealants and adhesives types, natural/biological sealants and adhesives origin and synthetic and semi-synthetic sealants and adhesives.
- On the basis of application, the Asia-Pacific biosurg1ery market is segmented into general surgery, cardiovascular surgery, orthopedic surgery, neurological surgery, reconstructive surgery, gynecological surgery, thoracic surgery and urological surgery.
Asia-Pacific Biosurgery Market Country Level Analysis
The Asia-Pacific biosurgery market is analysed and market size insights and trends are provided by country, product and application as referenced above.
The countries covered in the biosurgery market report are Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific.
Asia-Pacific is projected to exhibit the highest growth rate during the forecast period owing to the increasing awareness about surgical procedures, ever-rising geriatric population, and increased expenditure for the development of healthcare infrastructure.
The country section of the Asia-Pacific biosurgery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The Asia-Pacific biosurgery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific biosurgery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific biosurgery market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Asia-Pacific Biosurgery Market Share Analysis
The Asia-Pacific biosurgery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Asia-Pacific biosurgery market.
The major players covered in the Asia-Pacific biosurgery market report are BD, Baxter., Medical Devices Business Services, Inc., B. Braun Melsungen AG, CryoLife, Inc., Johnson & Johnson Services, Inc., Medtronic, Sanofi, Stryker, Hemostasis, LLC., Integra LifeSciences Corporation., Pfizer Inc., CSL Limited, Exactech, Inc., RTI Surgical, MAQUET Holding B.V. & Co. KG, SAMYANG BIOPHARMACEUTICALS CORPORATION., Aroa Biosurgery Limited, TELA Bio, Inc., Tissue Regenix, Osiris and Biosurge Healthcare India Private Limited among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-